| Date & Time | 4 April 2024 at 16:00 CET |
|---|---|
| Location | Virtual |
Join the virtual Patient Engagement Open Forum (PEOF) session on 4 April 2024, at 16:00 CET (15.00 UTC – 10.00 EDT), titled “Unlocking the Human Element: Integrating Patient Insights & Experiences into Precision Medicine Value Assessment” in collaboration with EFPIA and EPF.
In light of recent developments in Patient Engagement (PE), particularly the growing role of Patent Experience Data (PED) in drug development and the introduction of the new EU Regulation on Health Technology Assessments (HTA), it is both timely and necessary to examine the interplay between PE, PED, precision medicine, and HTAs.
This session will explore how PE and PED enhance patient-centric HTA. The panel and participants will discuss insights, explore the interconnectedness, and identify opportunities for PE and PED. Participants can share their views on how stakeholders support decision-makers in prioritizing #patientcentric value dimensions.
PEOF is the only multi-stakeholder event for shaping the future of patient engagement. It is a dynamic community of multicultural and multidisciplinary visionaries fervently uniting to forge a brighter and healthier tomorrow for patients, with patients. The Forum is a gateway to effect real change, bringing together an unparalleled network of patient advocates, industry pioneers, and regulatory powerhouses, both virtually and in person. The collective expertise and collaboration are crucial in fostering innovation and co-creating groundbreaking solutions that will redefine the future of patient engagement.
All PEOF Virtual sessions are now accessible in 50+ languages, with instant translations available for you to choose from during the live session.
Please share this invitation with your colleagues and networks who might find these panel discussions beneficial.
Remember to also join the upcoming virtual session “Navigating the Future of Healthcare: Ethical, Technological, and Social Dimensions of Patient Matchmaking” on 19 March 2024 at 14:30 CET (13.30 UTC – 9.30 EDT).
